Hims & Hers Health マネジメント
マネジメント 基準チェック /24
Hims & Hers Healthの CEO はAndrew Dudumで、 Jan2017年に任命され、 の在任期間は 7.83年です。 の年間総報酬は$ 14.40Mで、 4.2%給与と95.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の8.61%を直接所有しており、その価値は$ 476.70M 。経営陣と取締役会の平均在任期間はそれぞれ2.7年と2.9年です。
主要情報
Andrew Dudum
最高経営責任者
US$14.4m
報酬総額
CEO給与比率 | 4.2% |
CEO在任期間 | 7.8yrs |
CEOの所有権 | 8.6% |
経営陣の平均在職期間 | 2.7yrs |
取締役会の平均在任期間 | 2.9yrs |
経営陣の近況
Recent updates
Hims & Hers Health: The Amazon Curse Is Being Overstated
Nov 15Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow
Nov 05HIMS: GLP-1 Is Just The Beginning
Oct 17Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward
Oct 03Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 25% Share Price Bounce
Oct 01Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now
Sep 24Hims & Hers Health Post Q2 Earnings - Compounded GLP-1 Ploy Faces New Threats (Rating Downgrade)
Aug 27Hims & Hers: Digesting Q2 2024 Earnings, Shares Still Undervalued, Rating Downgrade
Aug 20Hims & Hers Health, Inc.'s (NYSE:HIMS) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Aug 11Hims & Hers Health: Buy The Dip, With Or Without The GLP-1 Shortage
Aug 07Hims & Hers: The Thesis Goes Far Beyond GLP-1
Jul 18Hims & Hers: Buy The Dip To Catch The Next Rip
Jun 24Why Investors Shouldn't Be Surprised By Hims & Hers Health, Inc.'s (NYSE:HIMS) 70% Share Price Surge
Jun 19Hims & Hers: The Undervalued Gem Poised For Growth
Jun 18Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable
Jun 10Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment
May 31Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
May 21Hims & Hers Health: An Unforced Error
May 06Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
May 04Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25CEO報酬分析
日付 | 総報酬 | 給与 | 会社業績 |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$101m |
Jun 30 2024 | n/a | n/a | US$18m |
Mar 31 2024 | n/a | n/a | -US$2m |
Dec 31 2023 | US$14m | US$612k | -US$24m |
Sep 30 2023 | n/a | n/a | -US$36m |
Jun 30 2023 | n/a | n/a | -US$47m |
Mar 31 2023 | n/a | n/a | -US$59m |
Dec 31 2022 | US$11m | US$600k | -US$66m |
Sep 30 2022 | n/a | n/a | -US$86m |
Jun 30 2022 | n/a | n/a | -US$83m |
Mar 31 2022 | n/a | n/a | -US$73m |
Dec 31 2021 | US$15m | US$574k | -US$108m |
Sep 30 2021 | n/a | n/a | -US$82m |
Jun 30 2021 | n/a | n/a | -US$72m |
Mar 31 2021 | n/a | n/a | -US$63m |
Dec 31 2020 | US$27m | US$527k | -US$18m |
Sep 30 2020 | n/a | n/a | -US$25m |
Jun 30 2020 | n/a | n/a | -US$38m |
Mar 31 2020 | n/a | n/a | -US$58m |
Dec 31 2019 | US$254k | US$254k | -US$72m |
報酬と市場: Andrewの 総報酬 ($USD 14.40M ) は、 US市場 ($USD 7.74M ) の同規模の企業の平均を上回っています。
報酬と収益: Andrewの報酬は、過去 1 年間の会社の業績と一致しています。
CEO(最高経営責任者
Andrew Dudum (35 yo)
7.8yrs
在職期間
US$14,401,411
報酬
Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...
リーダーシップ・チーム
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Founder | 7.8yrs | US$14.40m | 8.61% $ 476.7m | |
Chief Financial Officer | 2.8yrs | US$7.43m | 0.051% $ 2.8m | |
Chief Operating Officer | 3.8yrs | US$6.77m | 0.29% $ 16.0m | |
Chief Legal Officer & Corporate Secretary | 3.8yrs | US$5.21m | 0.077% $ 4.2m | |
Chief Medical Officer | 1.9yrs | US$198.26k | 0.088% $ 4.9m | |
Chief Commercial Officer | less than a year | US$6.71m | 0.084% $ 4.7m | |
Senior VP | 5.4yrs | US$961.12k | 0.0023% $ 129.5k | |
Chief Communications Officer | 1.1yrs | データなし | データなし | |
Senior Vice President of Human Resources | 2.7yrs | データなし | データなし | |
Senior VP & Member of Medical Advisory Board | no data | データなし | データなし | |
Chief Pharmacy & Innovation Officer | 1.9yrs | データなし | データなし | |
Senior Vice President of Mental Health | 1.7yrs | データなし | データなし |
2.7yrs
平均在職期間
44yo
平均年齢
経験豊富な経営陣: HIMSの経営陣は 経験豊富 であると考えられます ( 2.7年の平均在職年数)。
取締役
名称 | ポジション | 在職期間 | 報酬 | 所有権 |
---|---|---|---|---|
Co-Founder | 3.8yrs | US$14.40m | 8.61% $ 476.7m | |
Chief Medical Officer | 2.8yrs | US$198.26k | 0.088% $ 4.9m | |
Senior VP & Member of Medical Advisory Board | 2.8yrs | データなし | データなし | |
Independent Director | 4.2yrs | US$194.26k | 0.025% $ 1.4m | |
Lead Independent Director | 4.2yrs | US$227.41k | 0.071% $ 4.0m | |
Independent Director | 3.7yrs | US$205.51k | 0.033% $ 1.8m | |
Member of Medical Advisory Board | 2.9yrs | データなし | データなし | |
Member of Medical Advisory Board | no data | データなし | データなし | |
Member of Medical Advisory Board | 2.9yrs | データなし | データなし | |
Member of Medical Advisory Board | 2.9yrs | データなし | データなし | |
Member of Medical Advisory Board | 2.9yrs | データなし | データなし | |
Member of Medical Advisory Board | 2.9yrs | データなし | データなし |
2.9yrs
平均在職期間
53yo
平均年齢
経験豊富なボード: HIMSの 取締役会 は 経験豊富 ではない ( 2.9年の平均在任期間) ため、新しい取締役会が必要であると考えられます。